Insights Care brings you its edition of the '10 Most Innovative Regenerative Medicine Companies in 2021', embracing the journey of these companies with the profound expertise that is enabling innovations in the healthcare niche.
Recuperating Lost Skin Pigmentation
Through Advanced Cellular Therapy
TeVido
BioDevices
Innovative
0
MOST
Regenerative
Medicine
Companies in
2022
Medevolve
January
Issue 01
2022
Laura Bosworth
CEO, and Founder
The Application of
Stem Cell Therapy
A New Dawn
Could Regenerative Medicine
Be the Key to Treating
Malignant Diseases?
egenerative medicine is an interdisciplinary field
Rthat connects engineering and life science
principles to promote regeneration and can
conceivably restore diseased and injured tissues and organs.
Regenerative medicine encompasses numerous strategies,
including materials and newly generated cells and various
combinations, to take the place of missing tissue, effectively
replace it structurally and functionally, or contribute to
tissue healing.
The body's innate healing response may also be leveraged
to promote regeneration, although adult humans possess a
limited regenerative capacity than lower vertebrates. Organ
and Tissue loss through disease and injury motivates the
development of therapies that can regenerate tissues and
reliance on transplantations.
Since tissue engineering and regenerative medicine
emerged as an industry about two decades ago, several
therapies have received Food and Drug Administration
(FDA) clearance or approval and are commercially
available.
If compared with this scenario, medical devices, a vast
category that includes noncellular products, such as
acellular matrices, generally reach the market after only
three to seven years of development and may undergo an
expedited process if they are similar to these preexisting
devices.
Scientific and clinical progress has enabled the present era
of gene therapy and cell therapy on multiple fronts.
Acellular products may be preferable from a regulatory and
development perspective, compared with cell-based
products, due to the less arduous approval process.
On the brighter side, increased accuracy of disease models
may improve the efficacy of regenerative medicine
strategies and enhance